Loading...

MicroPort CardioFlow Medtech Corporation

2160.HK•HKSE
Healthcare
Medical - Devices
HK$1.31
HK$0.02(1.55%)

MicroPort CardioFlow Medtech Corporation (2160.HK) Company Profile & Overview

Explore MicroPort CardioFlow Medtech Corporation’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

MicroPort CardioFlow Medtech Corporation (2160.HK) Company Profile & Overview

MicroPort CardioFlow Medtech Corporation, a medical device company, researches, develops, and commercializes transcatheter and surgical solutions for structural heart diseases in the People's Republic of China. It offers Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set to target aortic, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company was founded in 2010 and is headquartered in Shanghai, China.

SectorHealthcare
IndustryMedical - Devices
CEOLuying Yan

Contact Information

https://www.cardioflowmedtech.com
86 21 3895 4600
Zhangjiang Hi-Tech Park, Shanghai, 201203

Company Facts

430 Employees
IPO DateFeb 4, 2021
CountryCN
Actively Trading

Frequently Asked Questions

;